Molecular Imaging Could Become the Standard for Prostate Cancer Tumor Staging
By MedImaging International staff writers Posted on 28 Jun 2016 |
Image: These images compare axial histopathology and axial PET/CT in six segments of the prostate gland of a patient (Photo courtesy of Ludwig-Maximilians-Universitat of Munich).
Researchers have shown that molecular imaging can help oncologists accurately detect and delineate prostate tumors during biopsies, and can also be used for pre-operative planning.
The researchers used Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) imaging and histopathology to evaluate prostate tumors of study participants. The researchers found that by using PET/CT imaging to evaluate Ga-68 PSMA tumor uptake, they were able to find all 67% of tissues found to be cancerous in a histological evaluation. PSMA is found on the surface of prostate cancer cells. The researchers used a combination of radioactive gallium-68 (Ga-68), and PSMA-HBED-CC a molecular compound to detect prostate cancer cells.
The researchers presented the results at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2016).
Wolfgang P. Fendler, MD, NM department, Ludwig-Maximilians Universitat Munchen (LMU; Munich, Germany), said, "PSMA shows significant over-expression on prostatic cancer cells and Ga-68 PSMA PET/CT demonstrates a high rate of detection in patients with recurrent, metastatic prostate cancer. However much less research has been conducted for the accuracy of PSMA imaging at the start of the disease. The results of our study indicate that Ga-68 PSMA PET/CT accurately identifies affected regions of the prostate and might thus present a promising tool for non-invasive tumor characterization and biopsy guidance."
Related Links:
Ludwig-Maximilians Universitat Munchen
The researchers used Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) imaging and histopathology to evaluate prostate tumors of study participants. The researchers found that by using PET/CT imaging to evaluate Ga-68 PSMA tumor uptake, they were able to find all 67% of tissues found to be cancerous in a histological evaluation. PSMA is found on the surface of prostate cancer cells. The researchers used a combination of radioactive gallium-68 (Ga-68), and PSMA-HBED-CC a molecular compound to detect prostate cancer cells.
The researchers presented the results at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2016).
Wolfgang P. Fendler, MD, NM department, Ludwig-Maximilians Universitat Munchen (LMU; Munich, Germany), said, "PSMA shows significant over-expression on prostatic cancer cells and Ga-68 PSMA PET/CT demonstrates a high rate of detection in patients with recurrent, metastatic prostate cancer. However much less research has been conducted for the accuracy of PSMA imaging at the start of the disease. The results of our study indicate that Ga-68 PSMA PET/CT accurately identifies affected regions of the prostate and might thus present a promising tool for non-invasive tumor characterization and biopsy guidance."
Related Links:
Ludwig-Maximilians Universitat Munchen
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection